Skip to main content
. 2017 Jun 6;8(30):49973–49987. doi: 10.18632/oncotarget.18385

Table 2. Summary of results of growth inhibition assays upon drug exposure for 4h.

Cell line Tubulysin B EC1009 Tubulysin B hydrazide EC0347 Tubulysin B bis ether EC1820
IC50, nM S.D. Fold resistance IC50, nM S.D. Fold resistance IC50, nM S.D. Fold resistance
KB-3-1 10.42 0.11 1.00 4.31 0.38 1.00 1.35 0.06 1.00
KB-V1 38.67 2.58 3.71 4,616.0 114.00 1,072.2 183.83 43.38 136.17
KB-V1+TQD 16.67 1.97 1.60 6.99 0.41 1.62 2.06 0.08 1.52
KB-V1-VBT 134.21 0.44 12.89 26,327.0 212.85 6,115.5 1,595.2 140.30 1,181.6
KB-V1-VBT+TQD 24.21 0.19 2.32 7.69 1.44 1.79 4.27 1.81 3.16

All differences shown as fold of resistance have a P-value ≤0.026.